PharmaPath
- Develops and manufactures high-quality generics
- Products in more than 120 countries
- Strong export and out-licensing activity
We partner with innovative medical device manufacturers to introduce, launch and grow their therapies in Greece, backed by one of the country's leading integrated healthcare groups.
Innovis Medical Devices S.A. is the medical technology company of Innovis Pharma. Launched in November 2022, it brings to Greek hospitals the cardiovascular and interventional technologies that change how patients are treated.
We focus where innovation moves fastest: interventional cardiology, structural heart, circulatory support, renal therapies and cath lab safety. Our team works side by side with interventional cardiologists, cardiac surgeons, electrophysiologists and nephrologists, from the first case to routine use across the country.
As a wholly owned member of a fully integrated Greek healthcare group, we combine a specialist medical devices team with the scale, market access know-how and financial strength of the Group.
In 2026 PharmaPath completed the acquisition of Innovis Pharma, creating a Greek group that spans research and manufacturing through to commercial excellence in pharmaceuticals, consumer health and medical devices.
We build portfolios around clinical pathways, so each new technology reaches the right specialists and complements the ones already in use.
Technologies for complex coronary disease and chronic total occlusions.
Transcatheter solutions for valve disease and congenital or acquired defects.
Programmes for protected high-risk PCI and cardiogenic shock.
Protecting the kidney during contrast procedures and treating resistant hypertension.
Consumables that make access safer and recovery faster.
Protecting staff and patients and bringing precision to complex procedures.
We represent technologies that bring measurable clinical value, and we treat every partner's brand as if it were our own.
Cath labs in Greece are spread across the mainland and the islands. Our field team and the Group's distribution network cover all of them.
A specialist medical devices team with the reach, credibility and resources of a leading Greek healthcare group.
Proven experience with HTA, pricing and reimbursement committees, and ongoing dialogue with the Ministry of Health, EOPYY and private insurers.
Close relationships with key opinion leaders and the Hellenic cardiology and cardiothoracic surgery societies, and links with Greek physicians working abroad.
Proctor development, international masterclasses and hands-on training for every member of the cath lab team.
National networks for high-risk PCI, cardiogenic shock and advanced therapies, with programmes that raise therapy awareness.
Presence in public and private hospitals, tender management, consignment stock and clinical case support.
A strong regulatory affairs team, vigilance and compliance, and Group logistics and customer service you can rely on.
Our ambition is to become a leading medical devices company in Greece, bringing cutting-edge therapies to Greek physicians and patients.
Tell us about your technology and your plans for Greece. Our business development team will come back to you to arrange an introductory meeting.